A detailed history of Northern Trust Corp transactions in Aziyo Biologics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 17,957 shares of AZYO stock, worth $26,037. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,957
Previous 13,809 30.04%
Holding current value
$26,037
Previous $20,000 30.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
N/A
4,148 Added 30.04%
17,957 $26,000
Q1 2024

May 14, 2024

BUY
N/A
485 Added 3.64%
13,809 $20,000
Q4 2023

Feb 13, 2024

BUY
$1.14 - $1.45 $15,189 - $19,319
13,324 New
13,324 $19,000
Q2 2021

Aug 13, 2021

SELL
$9.51 - $13.97 $239,937 - $352,463
-25,230 Closed
0 $0
Q1 2021

May 12, 2021

BUY
$13.08 - $16.41 $37,840 - $47,474
2,893 Added 12.95%
25,230 $348,000
Q4 2020

Feb 11, 2021

BUY
$10.77 - $14.82 $240,569 - $331,034
22,337 New
22,337 $304,000

Others Institutions Holding AZYO

About AZIYO BIOLOGICS, INC.


  • Ticker AZYO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 9,308,720
  • Market Cap $13.5M
  • Description
  • Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of inf...
More about AZYO
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.